BRIGHT MINDS BIOSCIENCES INC (DRUG:NASDAQ)
$76.78 -4.24 (-5.2333%)
Analysed BRIGHT MINDS BIOSCIENCES INC (DRUG:NASDAQ) News Sources
Bright Minds Biosciences Announces Positive Topline Results from Phase 2 Clinical Trial of BMB-101 in Patients with Absence Seizures and Developmental and Encephalopathic Epilepsies (DEE)
06-01-2026
yahoo.com
Bright Minds Biosciences Announces Launch of US$100 Million Public Offering
06-01-2026
yahoo.com
Bright Minds Biosciences Announces Pricing of Upsized US$175 Million Public Offering of Common Stock
08-01-2026
yahoo.com
Bright Minds Biosciences Announces Closing of US$175 Million Public Offering
09-01-2026
yahoo.com
Canadian Securities Exchange Reports January 2026 Performance Figures
17-02-2026
yahoo.com
Baird Lowers Bright Minds Biosciences Inc. (DRUG) Price Target to $126, Maintains Outperform Rating Ahead of Upcoming Trials
19-02-2026
yahoo.com
Bright Minds Biosciences to Present at Upcoming Conferences
25-02-2026
yahoo.com
Psychedelic: Helus Pharma reports HLP004 Phase 2 signal detection study results
06-03-2026
yahoo.com
What Is the Probability of Success for Bright Minds Biosciences Inc (DRUG)’s Lead Drug Candidate?
25-03-2026
yahoo.com
Why a $5 Million New Position Signals Confidence in This Epilepsy Drug Pipeline
21-05-2026
fool.com
What is the current price of BRIGHT MINDS BIOSCIENCES INC (DRUG:NASDAQ)?
The current price of BRIGHT MINDS BIOSCIENCES INC (DRUG:NASDAQ) is $76.78.
BRIGHT MINDS BIOSCIENCES INC (DRUG:NASDAQ) absolute price change since previous trading day?
The absolute price change of BRIGHT MINDS BIOSCIENCES INC (DRUG:NASDAQ) since the previous trading day is $-4.24.
BRIGHT MINDS BIOSCIENCES INC (DRUG:NASDAQ) percentage price change since previous trading day?
The percentage price change of BRIGHT MINDS BIOSCIENCES INC (DRUG:NASDAQ) since the previous trading day is -5.2333%.
What is the most recent average sentiment score for BRIGHT MINDS BIOSCIENCES INC (DRUG:NASDAQ)?
The most recent average sentiment score for BRIGHT MINDS BIOSCIENCES INC (DRUG:NASDAQ) is 70 out of 100.
What is the most recent average sentiment for BRIGHT MINDS BIOSCIENCES INC (DRUG:NASDAQ)?
The most recent sentiment for BRIGHT MINDS BIOSCIENCES INC (DRUG:NASDAQ) is .
SEC-8K** Filing Available For BRIGHT MINDS BIOSCIENCES INC (DRUG:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.